ABCB1 (P-glycoprotein) but not ABCC1 (MRP1) is downregulated in peripheral blood mononuclear cells of spontaneously hypertensive rats

Pflugers Archiv European Journal of Physiology

Volumn 456, Issue 2, 2008, Pages 359-368

  Valente, Raphael C ^a   Capella, Luiz S ^a   Nascimento, Clarissa R ^a   Braga, Filipe ^a   Echevarria Lima, Juliana ^a   Lopes, Aníbal G ^a   Capella, Márcia A M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

ABCB1; ABCC1; Flow cytometry; Hypertension; Multidrug resistance; PBMC

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HYPERTENSION; IMMUNE RESPONSE; KIDNEY; LYMPHOCYTE; LYMPHOID ORGAN; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; THYMOCYTE;

EID: 42049085264     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-007-0397-x     Document Type: Article

References (62)

1. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152-162
2. Gotesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427
3. Cordon-Cardo C, O'brien JP, Boccia J, Casals D, Bertino JR, Melamed MR (1990) Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38(9):1277-1287
4. Flens MJ, Zaman GJ, Van Der Valk P et al (1996) Tissue distribution of the multidrug resistance protein. Am J Pathol 148:1237-1247
5. Cole SP, Bhardwaj G, Gerlach JH et al (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258(5088):1650-1654
6. Cole SP, Deeley RG (1993) Multidrug resistance-associated protein: sequence correction. Science 260(5110):879
7. Albermann N, Schmitz-Winnenthal FH, Z'graggen K, Volk C, Hoffmann MM, Haefeli WE, Weiss J (2005) Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem Pharmacol 70(6):949-958
8. Neyfakh AA, Serpinskaya AS, Chervonsky AV, Apasov SG, Kazarov AR (1989) Multidrug-resistance phenotype of a subpopulation of T lymphocytes without drug selection. Exp Cell Res 185:496-505
9. Chaudhary PM, Mechetner EB, Roninson IB (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735-2739
10. + T cells: a role in cytotoxic effector function. J Clin Immunol 12:451-458
11. Raghu G, Park SW, Roninson IB, Mechetner EB (1996) Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp Hematol 24:1258-1264
12. Schinkel AH, Smit JJ, van Tellingen O et al (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502
13. Honig SM, Fu S, Mao X, Yopp A, Gunn MD, Randolph GJ, Bromberg JS (2003) FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. J Clin Invest 111(5):627-637
14. Dassa E, Bouige P (2001) The ABC of ABCs: a phylogenetic and functional classification of ABC systems in living organisms. Res Microbiol 152:211-229
15. Park SW, Lomri N, Simeoni LA, Fruehauf JP, Mechetner E (2003) Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay. Cytometry A 53A:67-78
16. Cole SP, Deeley RG (2006) Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol Sci 27(8):438-446
17. Osher E, Weisinger G, Limor R, Tordjman K, Stern N (2006) The 5 lipoxygenase system in the vasculature: emerging role in health and disease. Mol Cell Endocrinol 252(1-2):201-206
18. Zhuang H, Pin S, Li X, Dore S (2003) Regulation of heme oxygenase expression by cyclopentenone prostaglandins. Exp Biol Med (Maywood) 228(5):499-505
19. Musiek ES, Gao L, Milne GL (2005) Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J Biol Chem 280(42):35562-35570
20. Echevarria-Lima J, Kyle-Cezar F, Leite DFP, Capella L, Capella MA, Rumjanek VM (2005) Expression and activity of multidrug resistance protein 1 in a murine thymoma cell line. Immunology 114(4):468-475
21. van de Ven R, de Jong MC, Reurs AW et al (2006) Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation. J Immunol 176(9):5191-5198
22. Leite DFP, Echevarria-Lima J, Salgado LT, Capella MAM, Calixto JB, Rumjanek VM (2006) In vivo and in vitro modulation of MDR molecules in murine thymocytes. Int Immunopharmacol 6(2):204-215
23. Dahl LK, Heine M (1975) Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res 36:692-696
24. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethelm AG (1983) Remission of essential hypertension after renal transplantation. N Engl J Med 309:1009-1015
25. Johnson RJ, Rodríguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J (2005) A unifying pathway for essential hypertension. Am J Hypertens 18:431-440
26. Khraibi AA, Smith TL, Hutchins PM, Lynch CD, Dusseau JW (1987) Thymectomy delays the development of hypertension in Okamoto spontaneously hypertensive rats. J Hypertens 5(5):537-541
27. Ba D, Takeichi N, Kodama T, Kobayashi H (1982) Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J Immunol 128(3):1211-1216
28. Purcell ES, Wood GW, Gattone VH 2nd (1993) Immune system of the spontaneously hypertensive rat: II. Morphology and function. Anat Rec 237(2):236-242
29. Fannon LD, Braylan RC, Phillips MI (1992) Alterations in lymphocyte populations during development in the spontaneously hypertensive rat. J Hypertens 10:629-634
30. Pascual VH, Oparil S, Eldridge JH, Jin H, Bost KL, Pascual DW (1992) Spontaneously hypertensive rats: lymphoid depression is age dependent and mediated via a mononuclear cell subpopulation. Am J Physiol Regul Integr Comp Physiol 262:R1-R7
31. Chen CM, Schachter D (1993) Elevation of plasma immunoglobulin A in the spontaneously hypertensive rat. Hypertension 21:731-738
32. Suzuki H, Schmid-Schonbein GW, Suematsu M, DeLano FA, Forrest MJ, Miyasaka M, Zweifach BW (1994) Impaired leukocyte-endothelial cell interaction in spontaneously hypertensive rats. Hypertension 24:719-727
33. Suzuki H, Delano FA, Jamshidi N et al (1999) Enhanced DNA fragmentation in the thymus of spontaneously hypertensive rats. Am J Physiol 276(6 Pt 2):H2135-H2140
34. Sanz-Rosa D, Oubiña MP, Cediel E, de las Heras N, Vegazo O, Jiménez J, Lahera V, Cachofeiro V (2005) Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-κB/IκB system. Am J Physiol Heart Circ Physiol 288:H111-H115
35. Rodríguez-Iturbe B, Quiroz Y, Ferrebuz A, Parra G, Vaziri ND (2004) Evolution of renal interstitial inflammation and NF-kappa B activation in spontaneously hypertensive rats. Am J Nephrol 24(6):587-594
36. Aggarwal S, Tsuruo T, Gupta S (1997) Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans. J Clin Immunol 17(6):448-454
37. Ernest S, Bello-Reuss E (1999) Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells. J Am Soc Nephrol 10:2306-2231
38. Kerb R (2006) Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett 234(1):4-33
39. Shapiro HM, Schildkraut ER, Curbelo R, Turner RB, Webb RH, Brown DC, Block MJ (1977) Cytomat-R: a computer-controlled multiple laser source multiparameter flow cytophotometer system. J Histochem Cytochem. 25(7):836-844
40. Hoffman RA, Kung PC, Hansen WP, Goldstein G (1980) Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci USA 77(8):4914-4917
41. + peripheral blood cells. Clin Cancer Res 4(7):1727-1736
42. Morales MM, Capella MA, Sanches MV, Lopes AG, Guggino WB (2000) Modulation of the mdr-1b gene in the kidney of rats subjected to dehydration or a high-salt diet. Pflugers Arch 439(3):356-362
43. Nascimento CR, Braga F, Capella LS, Santos OR, Lopes AG, Capella MA (2005) Comparative study on the effects of cyclosporin A in renal cells in culture. Nephron Exp Nephrol 99(3):e77-e86
44. Gedeon C, Behravan J, Koren G, Piquette-Miller M (2006) Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta 27(11-12):1096-1102
45. Devault A, Gros P (1990) Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 10:1652-1663
46. Gros P, Buschman E (1993) The mouse multidrug resistance gene family: structural and functional analysis. Int Rev Cytol 137C:169-197
47. Ebringer A, Doyle AE (1970) Raised serum IgG levels in hypertension. Br Med J 2(5702):146-148
48. Olsen F, Rasmussen S (1977) Delayed hypersensitivity and borderline essential hypertension. Acta Pathol Microbiol Scand 85(3):196-198
49. Gudbrandsson T, Hansson L, Herlitz H, Lindholm L, Nilsson LA (1981) Immunological changes in patients with previous malignant essential hypertension. Lancet 1(8217):406-408
50. Mahmoud F, Omu A, Abul H, El-Rayes S, Haines D (2003) Lymphocyte subpopulations in pregnancy complicated by hypertension. J Obstet Gynaecol 23(1):20-26
51. Sukhai M, Yong A, Pak A, Piquette-Miller M (2001) Decreased expression of P-glycoprotein in interleukin-1 beta and interleukin-6 treated rat hepatocytes. Inflamm Res 50(7):362-370
52. Belliard AM, Lacour B, Farinotti R, Leroy C (2004) Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells. J Pharm Sci 93(6):1524-1536
53. Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, Jansen PL, Muller M (1998) Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28(6):1637-1644
54. Tofovic SP, Zacharia LC, Carcillo JA, Jackson EK (2000) Inhibition of cytokine release by and cardiac effects of type IV phosphodiesterase inhibition in early, profound endotoxaemia in vivo. Clin Exp Pharmacol Physiol 27(10):787-792
55. Manning RD Jr, Tian N, Meng S (2005) Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 25(4):311-317
56. Ando H, Zhou J, Macova M, Imboden H, Saavedra JM (2004) Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke 35(7):1726-1731
57. Rodríguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ (2001) The role of immunocompetent cells in non-immune renal diseases. Kidney Int 59:1626-1840
58. Quiroz Y, Pons H, Gordon KI et al (2001) Mycophenolate mofetil prevents the salt-sensitive hypertension resulting from short-term nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 281:F38-F47
59. Rodríguez-Iturbe B, Pons H, Quiroz Y et al (2001) Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59:2222-2232
60. Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chavez M, Herrera-Acosta J, Johnson RJ, Pons HA (2002) Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282(2):F191-F201
61. Ruiz-Ortega M, Esteban V, Ruperez M, Sanchez-Lopez E, Rodriguez-Vita J, Carvajal G, Egido J (2006) Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 15(2):159-166
62. Savoia C, Schiffrin EL (2006) Inflammation in hypertension. Curr Opin Nephrol Hypertens 15(2):152-158